Manulife (Manufacturers Life Insurance)’s Mustang Bio MBIO Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio MBIO Stock Details MBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-36	Closed	-$27.4K	–	3082
2022 Q1	$27.4K	Hold	36	–	–	﹤0.01%	3054
2021 Q4	$45	Sell	36 -2	-5%	-$3.23K	﹤0.01%	3095
2021 Q3	$76K	Sell	38 -3	-7%	-$6.44K	﹤0.01%	3113
2021 Q2	$101K	Buy	41 +7	+21%	+$17.2K	﹤0.01%	3204
2021 Q1	$84K	Sell	34 -17	-33%	-$50.5K	﹤0.01%	3054
2020 Q4	$145K	Buy	51 +28	+122%	+$66.9K	﹤0.01%	2875
2020 Q3	$55K	Buy	+23	New	+$56.7K	﹤0.01%	2886
2020 Q1	–	Sell	-14	Closed	-$43K	–	2867
2019 Q4	$43K	Buy	+14	New	+$32.1K	﹤0.01%	2852
2018 Q3	–	Sell	-1	Closed	-$6K	–	3493
2018 Q2	$6K	Hold	1	–	–	﹤0.01%	4039
2018 Q1	$10K	Hold	1	–	–	﹤0.01%	3915
2017 Q4	$9K	Buy	+1	New	+$7.74K	﹤0.01%	4001

Other funds holding MBIO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s MBIO Position: Q2 2022 in Review

Manulife (Manufacturers Life Insurance) sold out of Mustang Bio (MBIO) in Q2 2022, closing a stake of 36 shares — an estimated $27.4K sold.

Manulife (Manufacturers Life Insurance) first reported a position in MBIO in Q4 2017 and held it in 11 quarters. The position peaked at $145K in Q4 2020. 71 funds tracked by Wall St. Rank hold MBIO as of Q2 2022.

Manulife (Manufacturers Life Insurance) reported no remaining Mustang Bio position as of Q2 2022 after selling out during the quarter.
Manulife (Manufacturers Life Insurance) sold 36 Mustang Bio shares in Q2 2022, an estimated $27.4K.
Manulife (Manufacturers Life Insurance) first reported a position in Mustang Bio in Q4 2017 and held it in 11 quarters.
Manulife (Manufacturers Life Insurance)'s Mustang Bio position peaked at $145K in Q4 2020.
71 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2022.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2022, filed 15 Aug 2022.